• MIRA Pharmaceuticals reports oral formulation progress for MIRA-55 Investing.com Fri, 10 Jul 2026 13:33:23 GMT
• MIRA Pharmaceuticals announces positive preclinical results for MIRA-55 TipRanks Fri, 10 Jul 2026 12:35:33 GMT
• MIRA Pharmaceuticals Reports Successful Formulation Results Supporting Development of MIRA-55 as a Non-Opioid Oral Therapy for Chr... ACCESS Newswire Fri, 10 Jul 2026 12:07:59 GMT
• MIRA Pharmaceuticals (NASDAQ: MIRA) reports encouraging preclinical data for non-opioid pain candidate MIRA-55 Stock Titan Fri, 10 Jul 2026 12:00:51 GMT
• Experimental MIRA-55 pill shows brain and liver reach in pain studies Stock Titan Fri, 10 Jul 2026 12:00:00 GMT
• Mira reports results on optimized oral formulation of SKNY-1 BioWorld News Tue, 07 Jul 2026 13:00:00 GMT
• mira pharmaceuticals says skny-1 in obesity, addiction shows 'favorable' bioavailability in preclinical studies Moomoo Tue, 07 Jul 2026 00:32:42 GMT
• Mira Pharmaceuticals Says SKNY-1 in Obesity, Addiction Shows 'Favorable' Bioavailability in Preclinical Studies Moomoo Mon, 06 Jul 2026 13:44:17 GMT
• MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, Its Oral Drug Candidate for Obesity and Addiction Jonesboro Sun Mon, 06 Jul 2026 13:02:47 GMT
• MIRA Pharmaceuticals (MIRA) reports promising SKNY-1 preclinical pharmacokinetic and behavioral data Stock Titan Mon, 06 Jul 2026 13:00:50 GMT
• MIRA's obesity-and-addiction drug shows brain and liver exposure Stock Titan Mon, 06 Jul 2026 13:00:00 GMT
• mira pharmaceuticals | 4: statement of changes in beneficial ownership of securities-director whalen matthew pratt Moomoo Tue, 30 Jun 2026 03:29:24 GMT
• mira pharmaceuticals | 4: statement of changes in beneficial ownership of securities-director macpherson edward clouston - moomoo Moomoo Mon, 29 Jun 2026 13:53:31 GMT
• mira pharmaceuticals, inc.(nasdaqcm:mira) added to russell microcap growth benchmark index marketscreener.com Mon, 29 Jun 2026 12:40:47 GMT
• mira pharmaceuticals, inc.(nasdaqcm: mira) added to russell 3000e index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• price to earnings forward of mira pharmaceuticals, inc. – nasdaq:mira TradingView Sat, 27 Jun 2026 04:30:09 GMT
• enterprise value to revenue forward of mira pharmaceuticals, inc. – nasdaq:mira TradingView Fri, 26 Jun 2026 22:46:58 GMT
• price to sales forward of mira pharmaceuticals, inc. – nasdaq:mira TradingView Fri, 26 Jun 2026 22:46:35 GMT
• mira pharmaceuticals reports new preclinical data demonstrating mira-55's differentiated mechanism of action and anxiolytic activi... Black Hills Pioneer Fri, 26 Jun 2026 09:00:00 GMT
• mira pharmaceuticals, inc. actuals & estimates (fwb:k6s) TradingView Fri, 26 Jun 2026 06:12:12 GMT
• mira pharmaceuticals, inc. actuals & estimates (mun:k6s) TradingView Fri, 26 Jun 2026 01:48:36 GMT
• mira pharmaceuticals, inc. actuals & estimates (tradegate:k6s) TradingView Fri, 26 Jun 2026 00:58:38 GMT
• mira pharmaceuticals (nasdaq:mira) reports positive preclinical data for mira-55 in chronic inflammatory pain grafa.com Thu, 25 Jun 2026 16:58:00 GMT
• Mira Pharmaceuticals reports preclinical pharmacology data on Mira-55 TipRanks Thu, 25 Jun 2026 12:57:46 GMT
• MIRA Pharmaceuticals Reports New Preclinical Data Demonstrating Mira-55's Differentiated Mechanism of Action and Anxiolytic Activi... ACCESS Newswire Thu, 25 Jun 2026 12:22:52 GMT
• mira reports preclinical mira-55 data showing distinct mechanism, anxiolytic activity vs thc TradingView Thu, 25 Jun 2026 12:03:00 GMT
• Mira Pharmaceuticals reports preclinical data on pain drug candidate Investing.com Thu, 25 Jun 2026 07:00:00 GMT
• MIRA’s Mira-55 eases anxiety in preclinical tests, unlike THC Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• MIRA Pharmaceuticals (NASDAQ: MIRA) highlights differentiated Mira-55 preclinical profile vs. THC Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• MIRA Pharmaceuticals Advances Mira-55 for Chronic Pain Relief GuruFocus Thu, 25 Jun 2026 07:00:00 GMT
• mira pharmaceuticals inc (mira) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy ACCESS Newswire Fri, 19 Jun 2026 19:37:15 GMT
• mira pharmaceuticals declines further as stock approaches critical $0.90 support level - total put call dars.gov.et Fri, 19 Jun 2026 07:00:00 GMT
• mira pharmaceuticals submits phase 2a trial protocol to u.s. fda for ketamir-2 TipRanks Thu, 18 Jun 2026 08:28:39 GMT
• mira pharmaceuticals inc (mira) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 05:57:59 GMT
• telomir pharmaceuticals inc (telo) institutional confidence TradingKey Thu, 18 Jun 2026 05:49:09 GMT
• mira pharmaceuticals inc (mira) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 23:13:55 GMT
• mira pharmaceuticals inc (mira) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 23:04:20 GMT
• mira pharmaceuticals inc (mira) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 21:51:42 GMT
• mira pharmaceuticals inc (mira) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 21:51:29 GMT
• mira pharmaceuticals inc (mira) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 18:18:48 GMT
• mira pharmaceuticals inc (mira) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 18:17:20 GMT
• mira pharmaceuticals submits phase 2a clinical trial protocol to fda for ketamir-2 in chemotherapy-induced peripheral neuropathy Eagle-Tribune Wed, 17 Jun 2026 12:01:42 GMT
• MIRA Pharmaceuticals submits Phase 2a trial protocol for CIPN Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• Chemo nerve damage leaves millions without an approved drug; MIRA plans Ketamir-2 trial Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• phase 2a cipn trial protocol for ketamir-2 accepted, mira (nasdaq: mira) Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• mira pharmaceuticals inc (mira) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• mira pharmaceuticals inc (mira) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• Director receives 50,000 options at $0.94 at MIRA PHARMACEUTICALS, INC. (MIRA) Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• MIRA Pharmaceuticals grants director 50,000 stock options | MIRA Insider Trading Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• MIRA Pharmaceuticals (MIRA) grants director 50,000 stock options at $0.94 Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• mira pharmaceuticals (mira) director granted 50,000 stock options award Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• mira pharmaceuticals inc. (mira) edges higher: navigating key levels in a volatile sector - golden cross newsline.com Thu, 11 Jun 2026 00:46:12 GMT
• mira pharmaceuticals appoints new fractional chief financial officer The Globe and Mail Tue, 09 Jun 2026 22:48:00 GMT
• mira pharmaceuticals | 3: initial statement of beneficial ownership of securities- mushak andriy Moomoo Tue, 09 Jun 2026 07:00:00 GMT
• mira pharmaceuticals (mira) cfo andriy mushak listed as insider in form 3 Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• mira pharmaceuticals - alan weichselbaum to step down as cfo effective june 6, 2026 - sec filing TradingView Mon, 08 Jun 2026 21:17:06 GMT
• weekly roundup on the cannabis sector & psychedelic sector marketexclusive.com Mon, 08 Jun 2026 18:41:14 GMT
• Mira Pharmaceuticals appoints Andriy Mushak as fractional CFO Investing.com Mon, 08 Jun 2026 07:00:00 GMT
• MIRA appoints Andriy Mushak as fractional CFO as Alan Weichselbaum departs TradingView Mon, 08 Jun 2026 07:00:00 GMT
• mira pharmaceuticals (nasdaq: mira) hires fractional cfo via lmam Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• mira pharmaceuticals appoints new fractional chief financial officer TipRanks Mon, 08 Jun 2026 07:00:00 GMT
• mira pharmaceuticals holds steady at $1.0 as key support and resistance tested - advance decline line newsline.com Mon, 08 Jun 2026 07:00:00 GMT
• mira pharmaceuticals secures worldwide exclusive rights to mira-55 and skny-1 ACCESS Newswire Sun, 07 Jun 2026 16:48:26 GMT
• mira pharmaceuticals appoints andriy mushak as fractional cfo by investing.com Investing.com Nigeria Sat, 06 Jun 2026 07:00:00 GMT
• MIRA Pharmaceuticals (MIRA) Finds Support at $1.00 After Steep Decline - Volatility Term Structure dars.gov.et Fri, 05 Jun 2026 07:00:00 GMT
• mira pharmaceuticals secures worldwide rights to mira-55, skny-1 TipRanks Thu, 04 Jun 2026 22:27:40 GMT
• experimental obesity and chronic pain drugs now under mira's global control Stock Titan Thu, 04 Jun 2026 12:00:00 GMT
• MIRA Pharmaceuticals Secures Worldwide Exclusive Rights to MIRA-55 and SKNY-1 ACCESS Newswire Thu, 04 Jun 2026 07:00:00 GMT
• mira pharmaceuticals consolidates global rights for pipeline candidates mira-55 and skny-1 grafa.com Thu, 04 Jun 2026 07:00:00 GMT
• mira pharmaceuticals secures unified global rights to pipeline TipRanks Thu, 04 Jun 2026 07:00:00 GMT
• mira pharmaceuticals (nasdaq: mira) consolidates worldwide exclusive rights to mira-55 and skny-1 Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• mira pharmaceuticals faces subdued sentiment as stock dips toward key support - median line newsline.com Mon, 01 Jun 2026 07:00:00 GMT
• mira pharmaceuticals secures worldwide rights for ketamir-2 TipRanks Fri, 29 May 2026 04:18:45 GMT
• mira pharmaceuticals secures worldwide rights for ketamir-2, expanding global ip portfolio across 10 major markets ahead of phase ... Black Hills Pioneer Thu, 28 May 2026 09:00:00 GMT
• MIRA Pharmaceuticals Inc. (MIRA) Slips 8.66% to $1.05 as Technicals Test Key Support - Diamond Pattern dars.gov.et Thu, 28 May 2026 07:00:00 GMT
• mira pharmaceuticals q3 2025 earnings: eps beats estimates amid narrowing losses; stock declines - earnings call q&a newsline.com Thu, 28 May 2026 07:00:00 GMT
• mira pharmaceuticals enters into amendment no 1 to exclusive license agreement with miralogx marketscreener.com Wed, 27 May 2026 12:16:03 GMT
• mira pharmaceuticals secures worldwide rights for ketamir-2, expanding global ip portfolio across 10 major markets ahead of phase ... ACCESS Newswire Wed, 27 May 2026 12:05:18 GMT
• Experimental oral chemo nerve damage drug gets IP boost in 10 countries Stock Titan Wed, 27 May 2026 07:00:00 GMT
• MIRA Pharmaceuticals expands Ketamir-2 license to worldwide Investing.com Wed, 27 May 2026 07:00:00 GMT
• How RFID-Enabled Mira Care Can Bolster Hospital Cold Storage Resilience Pharmaceutical Commerce Wed, 27 May 2026 07:00:00 GMT
• mira pharmaceuticals (mira) expands ketamir-2 license to worldwide ip rights Stock Titan Wed, 27 May 2026 07:00:00 GMT
• mira pharmaceuticals edges higher, consolidating near key resistance at $1.04 - aaii bearish newsline.com Wed, 27 May 2026 07:00:00 GMT
• mira expands global ketamir-2 license for clinical development TipRanks Wed, 27 May 2026 07:00:00 GMT
• mira pharmaceuticals inc. (mira) nears support after marginal decline - fast moving stocks newsline.com Tue, 26 May 2026 07:00:00 GMT
• mira q3 2025 earnings: narrower-than-expected loss lifts shares - earnings stability report The Legal Advocate Tue, 26 May 2026 05:31:10 GMT
• mira q3 2025 earnings: narrowed loss surpasses expectations amid no revenue - cfo commentary report The Legal Advocate Fri, 22 May 2026 09:36:17 GMT
• mira technical analysis | trend, signals & chart patterns | mira pharmaceuticals inc (nasdaq:mira) ChartMill Fri, 22 May 2026 07:00:00 GMT
• mira stock price, quote & chart | mira pharmaceuticals inc (nasdaq:mira) ChartMill Fri, 22 May 2026 07:00:00 GMT
• mira pharmaceuticals (mira) q3 2025 earnings: why the beat matters - earnings momentum score newsline.com Wed, 20 May 2026 07:00:00 GMT
• what mira pharmaceuticals (mira)'s +1.35% jump means for investors 2026-05-18 - put call ratio newsline.com Mon, 18 May 2026 07:00:00 GMT
• mira pharmaceuticals (mira) q3 2025 earnings: why the beat matters - earnings call highlights newsline.com Sun, 17 May 2026 07:00:00 GMT
• should you sell mira pharmaceuticals (mira) after -1.24% drop? 2026-05-15 - jelly roll trade Newser Sat, 16 May 2026 01:26:27 GMT
• mira pharmaceuticals reports positive unblinded phase 1 data for ketamir-2 Black Hills Pioneer Fri, 15 May 2026 09:00:00 GMT
• mira pharmaceuticals (mira) delivers q3 2025 beat — eps $-0.06 vs $-0.08 expected - next quarter guidance The Legal Advocate Fri, 15 May 2026 07:00:00 GMT
• should you sell mira pharmaceuticals (mira) after -1.24% drop? 2026-05-15 - wave truncation The Legal Advocate Fri, 15 May 2026 07:00:00 GMT
• mira pharmaceuticals, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Thu, 14 May 2026 19:04:00 GMT
• mira announces results from phase 1 trial evaluating ketamir-2 TipRanks Thu, 14 May 2026 16:46:24 GMT
• mira pharmaceuticals stock gains on phase 1 trial results Investing.com Thu, 14 May 2026 07:00:00 GMT
• mira pharmaceuticals reports positive unblinded phase 1 data for ketamir-2 ACCESS Newswire Thu, 14 May 2026 07:00:00 GMT
• mira pharmaceuticals reports phase 1 results for ketamir-2 Investing.com Thu, 14 May 2026 07:00:00 GMT
• mira financials: income statement, balance sheet & cash flow Stock Titan Thu, 14 May 2026 07:00:00 GMT
• mira pharmaceuticals (mira) posts q1 2026 loss and warns on going concern Stock Titan Thu, 14 May 2026 07:00:00 GMT
• chemo nerve damage has no fda drugs—mira advances new ketamir-2 pill Stock Titan Thu, 14 May 2026 07:00:00 GMT
• mira announces acceptance of peer-reviewed skny-1 manuscript TipRanks Wed, 13 May 2026 16:51:28 GMT
• mira publishes preclinical study on obesity drug candidate skny-1 by investing.com Investing.com South Africa Wed, 13 May 2026 12:37:39 GMT
• mira pharmaceuticals announces acceptance of peer-reviewed skny-1 manuscript highlighting oral obesity and nicotine addiction drug... ACCESS Newswire Wed, 13 May 2026 12:07:06 GMT
• mira pharmaceuticals publishes preclinical skny-1 study showing weight loss, lipid benefits TradingView Wed, 13 May 2026 11:33:00 GMT
• fish study: mira test pill cuts weight 30% and dampens nicotine-seeking Stock Titan Wed, 13 May 2026 07:00:00 GMT
• mira pharmaceuticals announces peer-reviewed publication of skny-1 preclinical data Investing.com Wed, 13 May 2026 07:00:00 GMT
• mira pharmaceuticals (nasdaq: mira) highlights skny-1 preclinical obesity and nicotine data Stock Titan Wed, 13 May 2026 07:00:00 GMT
• mira pharmaceuticals announces publication of preclinical data on skny-1 for obesity and nicotine addiction in international journ... Minichart Wed, 13 May 2026 07:00:00 GMT
• mira pharmaceuticals reports positive phase 1 ketamir-2 results TipRanks Wed, 13 May 2026 07:00:00 GMT
• mira (mira) posts positive phase 1 data and dea decision on ketamir-2 Stock Titan Wed, 13 May 2026 07:00:00 GMT
• is mira pharmaceuticals (mira) stock hiding in plain sight? (wavering) 2026-05-11 - runaway gap The Legal Advocate Mon, 11 May 2026 07:00:00 GMT
• number of shareholders of mira pharmaceuticals, inc. – nasdaq:mira TradingView Sun, 10 May 2026 17:55:17 GMT
• mira pharmaceuticals reports mira-55 shows no thc- or rimonabant-associated cns side effects in preclinical studies ACCESS Newswire Thu, 07 May 2026 02:04:35 GMT
MIRA Pharmaceuticals, Inc.(NASDAQ:MIRA) 
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitiv...
Website: https://www.mirapharmaceuticals.com/
Founded: 2020
IPO Price: $7 (Aug 03, 2023)
CEO: Erez Aminov
Sector: ...
Industry: Pharmaceuticals
Share this website to your friends